# DESCRIPTION

## FIELD OF THE INVENTION

- introduce live attenuated virus vaccines

## BACKGROUND OF THE INVENTION

- describe RSV disease
- discuss limitations of current treatments
- introduce SYNAGIS
- discuss approaches to RSV vaccination
- motivate live-attenuated vaccines

## SUMMARY OF THE INVENTION

- describe recombinant RSV with attenuated phenotype
- outline embodiments of recombinant RSV

## DETAILED DESCRIPTION

### 1. Definitions

- define "about"
- define "a", "an", and "the"
- define "amino acid sequence"
- define "antibody"
- define "artificial mutation"
- define "attenuated phenotype"
- define "effective amount"
- define "expression of a gene"
- define "gene"
- define "host cell"
- define "immunogen" or "antigen"
- define "immunologically effective amount"
- define "introduced"
- define "isolated"
- define "nucleic acid"
- define "open reading frame"
- define "polypeptide"

### 2. Respiratory Syncytial Virus (RSV)

- describe RSV structure and genome
- describe RSV fusion protein F
- describe M2-2 gene and protein

### 3. Attenuated Virus

- define attenuated virus
- describe mutations for attenuation
- provide examples of attenuated RSV

### 4. M2-2 Deletion

- motivate M2-2 deletion
- describe M2-2 deletion mutants
- provide examples of M2-2 deletion
- describe nucleic acids encoding M2-2 deletion
- provide examples of nucleic acid sequences
- describe deletion of M2-2 protein
- provide examples of deletion percentages
- describe effect of M2-2 deletion on transcription
- describe effect of M2-2 deletion on replication

### 5. K66 Mutation

- introduce recombinant RSV with attenuated phenotype
- describe F subunit with mutated amino acid
- specify mutation at position 66
- define substituted amino acid
- categorize amino acids by side chain
- describe effect of positive side chain at position 66
- describe effect of negative side chain at position 66
- specify alternative positively charged amino acids
- describe combination of M2-2 mutation and F subunit substitution
- specify deletion of M2-2 protein
- describe percentage of deleted amino acid residues
- summarize nucleic acids encoding recombinant RSV

### 6. Vaccines

- introduce immunogenic compositions
- describe RSV vaccine with attenuated phenotype
- specify mutations in M2-2 and F subunit
- describe deletion of M2-2 protein
- specify percentage of deleted amino acid residues
- describe F subunit with negatively charged amino acid
- describe alternative embodiments of vaccine
- summarize physiologically acceptable carrier and/or adjuvant

### 7. Recombinant Expression

- define recombinant expression
- describe vector construction
- outline mutagenesis procedures
- reference protocols for viral nucleic acid manipulation

### 8. Cell Culture

- describe cell culture conditions
- reference cell culture protocols

### 9. Introduction of Vectors Into Host Cells

- describe vector introduction methods
- outline calcium phosphate co-precipitation
- outline electroporation
- outline microinjection
- outline lipofection
- outline polyamine transfection reagents
- describe transfection reagent usage
- outline electroporation usage
- describe vector introduction into host cells
- reference vector introduction methods

## WORKING EXAMPLES

- describe reagents and methods

### A. Introduction

- introduce RSV vaccines
- describe differences in growth kinetics
- motivate investigation of genetic determinants

### C. Identification of K66E as the Major Genetic Determinant for Altered Growth

- identify genetic determinants of growth differences

### D. A Change at Amino Acid 66 in RSV F Alters Fusion Activity

- analyze fusion activity of RSV F mutants

### E. A Positive Charge at Amino Acid 66 is Required for Efficient Fusion Activity

- test effect of charge on fusion activity
- confirm role of electrostatic interactions

### F. Materials and Methods

- describe cell lines and virus
- describe plasmids
- describe rescue of recombinant virus
- describe plaque assay
- describe multi-cycle growth analysis
- describe syncytium formation assay
- describe western blotting
- describe immunofluorescence and flow cytometry

